ebomi
Colour theme
Sign in
Insider · CIK 0001707230

Ponoi Capital, LP

CIK 0001707230 Name as filed on the most recent filing

Filed as Ponoi Capital, LP (78)

209 transaction lines · from 78 filings · filed 2017-10-30 to 2023-11-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2021-08-24 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 3,486 disposed 31.76 110,706.64 Form 4, filing 0000899243-21-034085
2021-08-24 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 3,463 disposed 31.76 109,978.30 Form 4, filing 0000899243-21-034085
2021-08-24 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 2,300 disposed 30.81 70,853.11 Form 4, filing 0000899243-21-034085
2021-08-24 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 2,200 disposed 30.79 67,739.98 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 13,623 disposed 31.40 427,809.88 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 12,969 disposed 31.41 407,373.15 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 12,354 disposed 31.42 388,123.15 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 8,204 disposed 30.94 253,855.55 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 7,605 disposed 30.93 235,197.55 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 7,278 disposed 30.92 225,026.30 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 2,200 disposed 32.35 71,167.80 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 2,100 disposed 32.38 68,004.51 Form 4, filing 0000899243-21-034085
2021-08-23 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 2,007 disposed 32.39 65,011.95 Form 4, filing 0000899243-21-034085
2021-08-20 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 1,670 disposed 30.07 50,222.24 Form 4, filing 0000899243-21-034085
2021-08-20 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 1,440 disposed 30.09 43,326.58 Form 4, filing 0000899243-21-034085
2021-08-20 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 1,429 disposed 30.08 42,984.61 Form 4, filing 0000899243-21-034085
2021-02-17 Constellation Pharmaceuticals Inc
CNST 		S, Open-market sale 10,000 disposed 36.95 369,503.00 Form 4, filing 0000899243-21-007420
2020-11-16 Revolution Medicines, Inc.
RVMD 		S, Open-market sale 1,075,133 disposed 36.40 39,134,841.20 Form 4, filing 0000899243-20-031483
2020-11-16 Revolution Medicines, Inc.
RVMD 		S, Open-market sale 952,023 disposed 36.40 34,653,637.20 Form 4, filing 0000899243-20-031483
2020-09-22 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 608,000 disposed 30.85 18,756,800.00 Form 4, filing 0001209191-20-051673
2020-09-02 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 27,595 acquired 17.67 487,603.65 Form 4, filing 0001209191-20-049487
2020-09-01 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 36,494 acquired 17.64 643,754.16 Form 4, filing 0001209191-20-049487
2020-08-28 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 26,135 acquired 17.89 467,555.15 Form 4, filing 0001209191-20-048798
2020-08-27 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 36,359 acquired 17.79 646,826.61 Form 4, filing 0001209191-20-048798
2020-08-25 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 100 acquired 18.00 1,800.00 Form 4, filing 0001209191-20-048294
2020-08-24 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 11,024 acquired 17.96 197,991.04 Form 4, filing 0001209191-20-048294
2020-08-21 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 7,321 acquired 17.97 131,558.37 Form 4, filing 0001209191-20-048294
2020-08-17 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 6,425 acquired 17.89 114,943.25 Form 4, filing 0001209191-20-046992
2020-08-17 Rapt Therapeutics, Inc.
RAPT 		S, Open-market sale 538,654 disposed 22.75 12,254,378.50 Form 4, filing 0001209191-20-047573
2020-08-14 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 37,993 acquired 17.49 664,497.57 Form 4, filing 0001209191-20-046992
2020-08-13 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 19,895 acquired 17.89 355,921.55 Form 4, filing 0001209191-20-046992
2020-07-30 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 732 acquired 17.99 13,168.68 Form 4, filing 0001209191-20-044543
2020-07-28 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 4,105 acquired 17.99 73,848.95 Form 4, filing 0001209191-20-044067
2020-07-27 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 3,834 acquired 17.99 68,973.66 Form 4, filing 0001209191-20-043875
2020-07-24 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 68,749 acquired 17.93 1,232,669.57 Form 4, filing 0001209191-20-043875
2020-07-22 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 193 acquired 18.00 3,474.00 Form 4, filing 0001209191-20-043529
2020-04-08 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 112,602 acquired 14.95 1,683,399.90 Form 4, filing 0001209191-20-024072
2020-04-07 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 123,728 acquired 14.38 1,779,208.64 Form 4, filing 0001209191-20-023862
2020-04-03 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 14,587 acquired 12.41 181,024.67 Form 4, filing 0001209191-20-023862
2020-04-02 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 14,850 acquired 12.40 184,140.00 Form 4, filing 0001209191-20-022767
2020-04-01 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 118,067 acquired 12.26 1,447,501.42 Form 4, filing 0001209191-20-022767
2020-03-31 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 118,067 acquired 12.53 1,479,379.51 Form 4, filing 0001209191-20-022767
2020-03-25 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 2,416 acquired 12.49 30,175.84 Form 4, filing 0001209191-20-021181
2020-03-24 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 128,377 acquired 12.22 1,568,766.94 Form 4, filing 0001209191-20-021181
2020-03-23 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 170,387 acquired 11.63 1,981,600.81 Form 4, filing 0001209191-20-021181
2020-03-20 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 143,082 acquired 11.77 1,684,075.14 Form 4, filing 0001209191-20-020683
2020-03-20 Constellation Pharmaceuticals Inc
CNST 		P, Open-market purchase 5,539 acquired 23.15 128,227.85 Form 4, filing 0001209191-20-020728
2020-03-19 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 148,464 acquired 11.59 1,720,697.76 Form 4, filing 0001209191-20-020683
2020-03-19 Constellation Pharmaceuticals Inc
CNST 		P, Open-market purchase 36,135 acquired 22.38 808,701.30 Form 4, filing 0001209191-20-020728
2020-03-05 NGM Biopharmaceuticals Inc
NGM 		P, Open-market purchase 8,307 acquired 18.00 149,526.00 Form 4, filing 0001209191-20-017015

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. PONOI CAPITAL, LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001707230

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.